OncoCyte Corporation

AMEX: OCXHealthcare / Diagnostic Substances / California, U.S.A
2.03+0.0600+3.05%Vol 126 8581Y Perf -14.04%
Aug 20th, 2019 16:00
BID0.0000 ASK0.0000
Open1.97 Previous Close1.97
Pre-Market- After-Trading-
 - -%  - -%
Target Price
7.05 
Analyst Rating
Strong Buy 1.00
Potencial %
247.29 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)106 
Earnings Rating
Buy
Price Range Ratio 52wk %
15.10 
Earnings Date
14th Aug 2019

Today's Price Range

1.912.05

52wk Range

1.166.92

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-2.87%
1 Month
-1.46%
3 Months
-59.80%
6 Months
-49.25%
1 Year
-14.04%
3 Years
-51.78%
5 Years
-
10 Years
-

Name / TickerPriceChg.Chg.%
OCX2.030.06003.05
AAPL210.610.26000.12
GOOG1 182.69-15.7600-1.32
MSFT137.26-1.1500-0.83
XOM69.03-0.4200-0.60
WFC44.68-0.5700-1.26
JNJ130.60-1.6500-1.25
FB183.81-2.3600-1.27
GE8.38-0.2900-3.34
JPM107.31-1.3800-1.27
Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.10-0.100.00
Q01 2019-0.10-0.0820.00
Q04 2018-0.09-0.11-22.22
Q03 2018-0.09-0.0722.22
Q02 2018-0.10-0.12-20.00
Q01 2018-0.13-0.127.69
Q04 2017--0.13-
Q03 2017-0.13-0.127.69
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.090.00-
12/2019 QR-0.0918.18Positive
12/2019 FY-0.372.63Positive
12/2020 FY-0.434.44Positive
Next Report Date-
Estimated EPS Next Report-0.10
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume126 858
Shares Outstanding (in ths.)51 973
Trades Count566
Dollar Volume405 488
Avg. Volume698 981
Avg. Weekly Volume185 417
Avg. Monthly Volume206 429
Avg. Quarterly Volume357 156
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

OncoCyte Corporation

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, the company also developing screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through United States and it earns revenue from the sale of diagnostic tests.

CEO: William Annett

Teplephone: +1 510 775-0515

Address: 1010 Atlantic Avenue, Alameda 94501, CA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

64%36%

News